Outliers with Daniel Scrivner: Explore the Greatest Innovators, Founders, and Investors cover image

#47 Mindbloom: On Psychedelics and Democratizing Access to Psychedelic Therapy | Jack Swain, Head of Clinical Operations

Outliers with Daniel Scrivner: Explore the Greatest Innovators, Founders, and Investors

00:00

Psychodelic Therapy

In the 19 sixties, there was this wave of psychodelich therapy that was happening. You can still go back and read those studies, and there are really profound effects. But things just kind of stopped, and that never moved forward. And so we're back on the right path. It looks like the f d ais on board. Great institutions like maps johns hopkins are really leading the charge. They were really excited to play our role in the clinical delivery of these medications.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app